Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 12, 2025International Journal of Clinical Inventions and Medical Sciences (IJCIMS)

Nanotechnology-Based Drug Delivery Systems for Targeted Cancer Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMaria DansCTConcepcion Mae ToqueroLALiane Regulacio Alampah

Discussion

Loading...

Member takes

Overview

This systematic review evaluates the efficacy and safety of nanotechnology in cancer therapy, indicating enhanced precision in treatment.

Key Points

  • Nanotechnology-based drug delivery systems significantly enhance bioavailability and tumor-specific accumulation.
  • Liposomal doxorubicin has improved survival compared to conventional chemotherapy, reducing cardiotoxicity.
  • Challenges like regulatory hurdles and long-term biocompatibility need to be addressed for broader adoption.
  • Future research should focus on personalized nanomedicine and scalable production for effective translation.

Cite This Study

Dans et al. (2025) studied this question.

synapsesocial.com/papers/68ebabe3155248a327effab8https://doi.org/10.36079/lamintang.ijcims-0702.911
View Full Paper
Ask AI
Bookmark
Share